Sorry, you need to enable JavaScript to visit this website.

Plain Language Study Results Summaries

What Are Plain Language Study Results Summaries?

Plain Language Study Results Summaries are descriptions in everyday language of the design and results of clinical studies. These summaries (also called layperson summaries, plain language summaries, lay language summaries, simple summaries, and trial results summaries) are intended to make the clinical results of these studies understandable and accessible to patients, healthcare providers, caregivers, researchers, and a general audience.

Please use the search function below to find Plain Language Study Results Summaries for Pfizer-sponsored global clinical trials.  For more information about a specific study, please visit ClinicalTrials.gov on the ClinicalTrials.gov Identifier (NCT) link on the study results page.

Filter Results

Refine your search results by using the dropdown filters below. Click “reset” to return to the full list of available studies.

Category & Conditions: Neurological Diseases and Conditions
Study Phase : 3
Medicine: VYNDAQEL® (TAFAMIDIS MEGLUMINE) CAPSULES AND VYNDAMAX™ (TAFAMIDIS) CAPSULES
PrintDownload
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 4
Medicine: XELJANZ®(TOFACITINIB)
PrintDownload
Category & Conditions: Immune System Diseases and Conditions
Study Phase : 3
Medicine: XELJANZ®(TOFACITINIB)
PrintDownload
Category & Conditions: Skin Diseases and Conditions
Study Phase : 3
Medicine: abrocitinib (PF-04965842)
PrintDownload